Non-disclosure of a pregnant woman's HIV status to her partner is associated with non-optimal prevention of mother-to-child transmission

AIDS and Behavior

Volumn 17, Issue 2, 2013, Pages 488-497

  Jasseron, C ^a,b   Mandelbrot, L ^a,c,d   Dollfus, C ^h   Trocme N ^h   Tubiana, R ^e,f   Teglas, J P ^a   Faye, A ^c,g   Rouzioux, C ^c,i   Blanche, S ^c,i   Warszawski, J ^a,b  

^a CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^b BICÊTRE HOSPITAL   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d HÔPITAL LOUIS MOURIER   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f INSERM   (France)

^g HÔPITAL ROBERT DEBRÉ   (France)

^h ARMAND TROUSSEAU HOSPITAL   (France)

ⁱ HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Access to care; HIV AIDS; Non disclosure during pregnancy; Prevention of mother to child transmission; Public health

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ARTICLE; ATTITUDE TO HEALTH; COUNSELING; DISEASE TRANSMISSION; EDUCATIONAL STATUS; FEMALE; FRANCE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERPERSONAL COMMUNICATION; MALE; MOTHER; MULTICENTER STUDY; PATIENT ATTITUDE; PREGNANCY; PREGNANCY COMPLICATION; PRENATAL CARE; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; SEXUALITY; SPOUSE; STATISTICS; UTILIZATION REVIEW; VERTICAL TRANSMISSION; VIRUS LOAD;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COUNSELING; EDUCATIONAL STATUS; FEMALE; FRANCE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV SEROPOSITIVITY; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; MOTHERS; PATIENT ACCEPTANCE OF HEALTH CARE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE; QUESTIONNAIRES; SEXUAL PARTNERS; SPOUSES; TRUTH DISCLOSURE; VIRAL LOAD;

MLCS; MLOWN;

EID: 84879846005     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-011-0084-y     Document Type: Article

References (29)

1. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS clinical trials group protocol 076 study group. N Engl J Med. 1994;331(18):1173-80.
2. Warszawski J, Tubiana R, Le Chenadec J, et al. Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort. AIDS. 2008;22(2):289-99.
3. Cooper ER, Charurat M, Mofenson L, et al. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr. 2002;29(5):484-94.
4. Mandelbrot L, Landreau-Mascaro A, Rekacewicz C, et al. Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1. JAMA. 2001;285(16):2083-93.
5. European Collaborative Study. Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin Infect Dis. 2005;40:458-65.
6. Newell ML, Huang S, Fiore S, et al. Characteristics and management of HIV-1-infected pregnant women enrolled in a randomised trial: differences between Europe and the USA. BMC Infect Dis 2007;7:60.
7. Townsend CL, Cortina-Borja M, Peckham CS, de Ruiter A, Lyall H, Tookey PA. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006. AIDS. 2008;22(8):973-81.
8. Centers for Diseases Control and Prevention. Achievements in public health. Reduction in perinatal transmission of HIV infection-United States, 1985-2005. MMWR Morb Mortal Wkly Rep. 2006;55(21):592-7.
9. Yeni P. Prise en charge médicale des personnes infectées par le VIH. Paris. France: Flammarion Médecine-Sciences; 2008.
10. Aluisio ABR, Jhon-Stewart G, Mbori-Ngacha D, Farquhar C. Male partner HIV-1 testing and antenatal clinic attendance associated with reduced infant HIV-1 acquisition and mortality. Cap Town: IAS; 2009.
11. Medley A, Garcia-Moreno C, McGill S, Maman S. Rates, barriers and outcomes of HIV serostatus disclosure among women in developing countries: implications for prevention of mother-to-child transmission programmes. Bull World Health Organ. 2004;82(4):299-307.
12. Farquhar C, Kiarie JN, Richardson BA, et al. Antenatal couple counseling increases uptake of interventions to prevent HIV-1 transmission. J Acquir Immune Defic Syndr. 2004;37(5):1620-6.
13. Sigxaxhe T, Mathews C. Determinants of disclosure by HIV positive women at khayelitsha mother to child transmission pilot project. Durban: International Conference on AIDS Jul 9-14; 2000.
14. Antelman G, Smith Fawzi MC, Kaaya S, et al. Predictors of HIV-1 serostatus disclosure: a prospective study among HIV-infected pregnant women in Dar es Salaam, Tanzania. AIDS. 2001;15:1865-74.
15. Diagne Gueye NR, Dolfus C, Tabone MD, et al. Psychosocial issues in HIV positive women during the perinatal period. Archives de pédiatrie. 2007;14(5):461-6.
16. Theuring S, Mbezi P, Luvanda H, Jordan-Harder B, Kunz A, Harms G. Male involvement in PMTCT services in Mbeya Region, Tanzania. AIDS Behav. 2009;13(1):92-102.
17. Makin JD, Forsyth BW, Visser MJ, Sikkema KJ, Neufeld S, Jeffery B. Factors affecting disclosure in South African HIV-positive pregnant women. AIDS Patient Care STDS. 2008;22(11):907-16.
18. Brou H, Djohan G, Becquet R, et al. When do HIV-infected women disclose their HIV status to their male partner and why? A study in a PMTCT programme, Abidjan. PLoS Med. 2007;4(12):e342.
19. Tubiana R, Matheron S, Le Chenadec J, et al. Extremely low risk of mother-to-child transmission of HIV in women starting HAART before pregnancy in the French perinatal cohort (ANRS EPF CO1/11). Boston: CROI; 2011.
20. SAS Institute. SAS User's guide: basics, version 9 edition: Cary: SAS Institute Inc.; 2006.
21. Forbes KM, Lomax N, Cunningham L, et al. Partner notification in pregnant women with HIV: findings from three inner-city clinics. HIV Med. 2008;9(6):433-5.
22. Peretti-Watel P, Spire B, Pierret J, Lert F, Obadia Y. Management of HIV-related stigma and adherence to HAART: evidence from a large representative sample of outpatients attending French hospitals (ANRS-EN12-VESPA 2003). AIDS Care. 2006;18(3):254-61.
23. Jasseron C, Mandelbrot L, Tubiana R, et al. Prevention of mother-to-child HIV transmission: similar access for sub-Sahara African immigrants and for French women? AIDS. 2008;22(12):1503-11.
24. Preau M, Marcellin F, Carrieri MP, Lert F, Obadia Y, Spire B. Health-related quality of life in French people living with HIV in 2003: results from the national ANRS-EN12-VESPA Study. AIDS. 2007;21(1):S19-27.
25. Sayles JN, Wong MD, Kinsler JJ, Martins D, Cunningham WE. The association of stigma with self-reported access to medical care and antiretroviral therapy adherence in persons living with HIV/AIDS. J Gen Intern Med. 2009;24(10):1101-8.
26. Wolitski RJ, Pals SL, Kidder DP, Courtenay-Quirk C, Holtgrave DR. The effects of HIV stigma on health, disclosure of HIV status, and risk behaviour of homeless and unstably housed persons living with HIV. AIDS Behav. 2009;13(6):1222-32.
27. Stirratt MJ, Remien RH, Smith A, Copeland OQ, Dolezal C, Krieger D. The role of HIV serostatus disclosure in antiretroviral medication adherence. AIDS Behav. 2006;10(5):483-93.
28. Sherr L, Lampe F, Norwood S, et al. Adherence to antiretroviral treatment in patients with HIV in the UK: a study of complexity. AIDS Care. 2008;20(4):442-8.
29. Desgrees du Lou A, Brou H, Djohan G, et al. Beneficial effects of offering prenatal HIV counselling and testing on developing a HIV preventive attitude among couples. Abidjan, 2002-2005. AIDS Behav. 2009;13(2):348-55.